A screening and treatment programme to deal with perinatal anxiety and depression during the COVID-19 pandemic.

Indicazioni di un programma di screening e trattamento per la gestione dell’ansia e della depressione perinatale nell’emergenza e post-emergenza COVID-19.

Journal

Epidemiologia e prevenzione
ISSN: 1120-9763
Titre abrégé: Epidemiol Prev
Pays: Italy
ID NLM: 8902507

Informations de publication

Date de publication:
Historique:
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 20 1 2021
Statut: ppublish

Résumé

During a pandemic, pregnancy and the postnatal period are complicated by multiple factors. On the one hand, worries about one's own health and the health of loved ones, in particular of the newborn child, can increase the risk of some mental disorders, such as depression and anxiety in the pregnant woman. On the other hand, as happened for the COVID-19 epidemic in Italy, given the need for physical distancing, the maintenance of the social and family network, so important for new parents in the perinatal period, is lacking. In addition, health services are forced to reorganize their offerings to ensure maximum safety for their operators and patients. This work proposes a model of screening and treatment aimed at identifying women at risk and providing them with effective and safe treatment.

Identifiants

pubmed: 33412831
doi: 10.19191/EP20.5-6.S2.139
pii: 5268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-373

Auteurs

Laura Camoni (L)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Fiorino Mirabella (F)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma; fiorino.mirabella@iss.it.

Gabriella Palumbo (G)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Debora Del Re (D)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Antonella Gigantesco (A)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Gemma Calamandrei (G)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Gina Barbano (G)

AULSS2 Marca Trevigiana, Treviso.
Ordine degli psicologi del Veneto.

Marina Cattaneo (M)

Azienda sociosanitaria territoriale Bergamo Ovest, Bergamo.

Sonia Brescianini (S)

Centro di riferimento per le scienze comportamentali e la salute mentale, Istituto superiore di sanità, Roma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH